Funder
American Federation for Aging Research
Paul Glenn Foundation for Medical Research
National Institute on Aging
National Institute of General Medical Sciences
Division of Loan Repayment
Publisher
Springer Science and Business Media LLC
Subject
Geriatrics and Gerontology,Ageing
Reference168 articles.
1. (IOM) (2010) Evaluation of biomarkers and surrogate endpoints in chronic disease. 2101 CONSTITUTION AVE, WASHINGTON, DC 20418 USA
2. Abualsuod A, Rutland JJ, Watts TE, Pandat S, Delongchamp R, Mehta JL (2015) The effect of metformin use on left ventricular ejection fraction and mortality post-myocardial infarction. Cardiovasc Drugs Ther 29:265–275.
https://doi.org/10.1007/s10557-015-6601-x
3. Administration FaD (2018) Early Alzheimer’s disease: developing drugs for treatment guidance for industry. Rockville, MD
4. Allard JS, Perez EJ, Fukui K, Carpenter P, Ingram DK, Cabo R (2015) Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice. Behav Brain Res 301:1–9.
https://doi.org/10.1016/j.bbr.2015.12.012
5. Andreassen M, Raymond I, Kistorp C, Hildebrandt P, Faber J, Kristensen LO (2009) IGF1 as predictor of all-cause mortality and cardiovascular disease in an elderly population. Eur J Endocrinol 160:25–31.
https://doi.org/10.1530/EJE-08-0452
Cited by
242 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献